Medicinal Products

Lotan H 50 mg + 12,5 mg filmom obložene tablete

Name Lotan H 50 mg + 12,5 mg filmom obložene tablete
Marketing Authorisation Number HR-H-006955471
Active Substance losartankalij
hidroklorotiazid
Composition 1 filmom obložena tableta sadrži 50 mg losartankalija i 12,5 mg hidroklorotiazida
Pharmaceutical Form filmom obložena tableta
Manufacturer mibe GmbH Arzneimittel, Brehna, Njemačka
Marketing Authorisation Holder Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska
Marketing Authorisation Date 13.01.2020
MA Period of Validity unlimited
MA Revocation Date 29.09.2023*
Classification Number UP/I-530-09/17-02/299
Registration Number 381-12-01/30-20-20
Prescription Medicinal product subject to medical prescription
Type of prescription ponovljivi recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code C09DA01
Marketing status trajni prekid opskrbe
SmPC download
PL download

*Note

Marketing authorisation has been revoked by request of the marketing authorisation holder. In accordance with Article 113 of Medicinal Products Act (Official Gazette No. 76/13), only a medicinal product in respect of which a marketing authorisation has been granted by the Agency for Medicinal Products and Medical Devices or the European Commision, and a medicinal product in respect of which an authorisation for parallel import or parallel distribution has been granted may be placed on the market of the Republic of Croatia. By way of derogation from this provision, a batch of medicinal product may be on the market for no longer than 18 months following the expiry of revocation of the marketing authorisation, unless its shelf life expires first.

Packaging

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od nemelanomskog raka kože povezanog s primjenom hidroklorotiazida 17.10.2018 Alkaloid, Belupo, Berlin-Chemie Menarini, Boehringer Ingelheim International, Farmal, Genericon, Pharma, Jadran Galenski laboratorij, Krka - farma, Merck, Merck Sharp & Dohme, Novartis, PharmaSwiss, Pliva, Sandoz, sanofi-aventis i Stada
Back